You must log in to view this page.

Collegium Pharmaceutical Inc. – Filings and Transcripts

NASDAQ: COLL
Share price (7/6/26): $37.47
Market cap (7/6/26): $1.215 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Freund John Gordon

Glancy Donovan Michael

Glancy Donovan Michael

Freund John Gordon

News Filter

Consolidated Financial Statements and Report of Independent Certified Public Accountants Corium Therapeutics Holdings, LLC December 31, 2025 and 2024

Shareholder Vote Results

Completes Acquisition of AZSTARYS® From Corium Therapeutics

Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness